Randomized controlled trial of the NS5A inhibitor daclatasvir plus peginterferon and ribavirin for HCV genotype-4 (COMMAND-4)
Hézode, Christophe, Alric, Laurent, Brown, Ashley, Hassanein, Tarek, Rizzetto, Mario, Buti, Maria, Bourlière, Marc, Thabut, Dominique, Molina, Esther, Rustgi, Vinod, Samuel, Didier, McPhee, Fiona, LiuVolume:
20
Year:
2015
Language:
english
Journal:
Antiviral Therapy
DOI:
10.3851/IMP2985
File:
PDF, 254 KB
english, 2015